SynthesisBMC public health2025
Associations between IPV and non-communicable diseases: a systematic review.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Women's empowerment and health: nationwide insights on selected non-communicable conditions in Bangladesh.BMC public health · 2026Article
- Complete Blood Count Profile in Steady State Sickle Cell Disease Patient: A Systematic Review and Meta-Analysis.Health science reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntimate partner violence (IPV) is associated with a range of adverse physical health outcomes; however, its specific influence on the health trajectories of individuals living with chronic disease remains underexplored. This systematic review investigates the intersection of IPV and non-communicable diseases (NCDs), with a focus on four leading conditions: cardiovascular disease, cancer, chronic respiratory disease, and diabetes. Advancing understanding in this area is essential for informing the development of targeted IPV prevention and intervention strategies, improving clinical care for affected populations, and shaping health equity policy responses.
methodsGuided by the research question, "How does experiencing IPV influence the burden, progression, or management of non-communicable diseases among adults diagnosed with cardiovascular disease, cancer, chronic respiratory disease, or diabetes?", the review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were conducted in PubMed, Scopus, and PsycINFO, yielding 39 eligible studies. Included studies focused on adults diagnosed with at least one of the four target NCDs, experiences of IPV occurring in adulthood, and assessed outcomes related to disease burden, progression, or healthcare management. Findings were synthesized narratively due to heterogeneity in study designs, populations, and IPV measurement. A Risk of Bias assessment was completed using JBI Critical Appraisal Tools.
resultsThe review identified consistent positive associations between IPV and adverse outcomes across cancer, diabetes, cardiovascular disease, and chronic respiratory disease, based on findings from 39 studies. Cancer emerged as the most frequently studied condition, with 19 publications, of which 14 focused specifically on breast or gynecological cancers. In contrast, research on the other NCDs was more limited, revealing an uneven distribution of scholarly attention and underscoring important gaps for future investigation. Risk of bias appraisal showed that 94.9% (n = 37) of studies had a low risk of bias, while 5.1% (n = 2) were rated as having moderate risk. Across study designs, the most frequent methodological concern was related to the reliability and validity of IPV survey instruments.
conclusionsThis review highlights a growing body of evidence linking IPV with worsened outcomes for individuals living with NCDs. To advance the field, future research should prioritize the development and implementation of IPV screening tools tailored to NCD populations, adopt standardized IPV definitions and measurement strategies, and expand the use of longitudinal designs to better understand causal pathways and long-term health impacts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.